2021 Germany Molecular Diagnostics Market Assessment--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests--Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

This new 1,125-page report from LeadingMarketResearch.com contains 58 tables.

The report is available by section, and can be customized to specific information needs and budget. The report presents comprehensive analysis of the German molecular diagnostics market, including:

  • Major issues pertaining to the German molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Ten-year test volume and reagent sales forecasts for the following categories:

   -  Infectious Diseases

 

   -  Genetic Diseases

 

   -  Cancer

 

   -  Paternity Testing/HLA Typing

 

   -  Forensic Testing

 

  • Review of testing methodologies an instrumentation technologies.
  • Feature comparison of automated and semiautomated analyzers.
  • Sales and market shares of leading suppliers.
  • Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.

Contains 1,125 pages and 58 tables This new 1,125-page report from LeadingMarketResearch.com contains 58 tables, and presents a comprehensive analysis of the German molecular diagnostics market, including:

  • Major issues pertaining to the German molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Ten-year test volume and reagent sales forecasts for the following categories:

   -  Infectious Diseases

 

   -  Genetic Diseases

 

   -  Cancer

 

   -  Paternity Testing/HLA Typing

 

   -  Forensic Testing

 

  • Review of testing methodologies an instrumentation technologies.
  • Feature comparison of automated and semiautomated analyzers.
  • Sales and market shares of leading suppliers.
  • Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.

Contains 1,125 pages and 58 tables

 

Introduction
 II. Major Product Development Opportunities
 A. Instrumentation
 B. Reagent Kits and Test Systems/panels
 C. Computers, Software and Automation
 D. Auxiliary Products
 III. Design Criteria for Decentralized Testing Products
 IV. Alternative Market Penetration Strategies
 A. Internal Development
 B. Collaborative Arrangements
 C. University Contracts
 D. Distribution Strategies for Decentralized Testing
 Markets
 V. Potential Market Entry Barriers and Risks
 A. Market Maturity
 B. Cost Containment
 C. Competition
 D. Technological Edge and Limitations
 E. Patent Protection
 F. Regulatory Constraints
 G. Decentralized Testing Market Challenges
 VI. Market and Technology Review
 A. DNA Sequencing
 1. Introduction
 2. Sequencing Methods
 3. Autoradiography
 4. The Human Genome Project
 5. Sequencing Automation
 6. Image Scanners
 7. Fluorescent Detection
 8. Gene Profiling
 9. Gene Expression
 10. Polymorphism Screening
 11. Protein Interaction Networks
 B. DNA and RNA Probe Technologies
 1. Basic Principles
 2. Probe Preparation
 3. The DNA Probe Test
 4. Test Formats
 5. Labeling Techniques
 6. Amplification Methods
 C. Detection Technologies
 1. Radioactive Methods
 2. Non-Isotopic Methods
 D. Instrumentation
 Review of latest analyzers from Abbott, Beckman Coulter/Danaher,
  Becton Dickinson, bioMerieux, Bio-Rad, Cepheid, Hologic, Qiagen, Roche,
 †Siemens Healthineers, and others.
 E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
 F. Pharmacogenomics
 G. Major Applications
 1. Microbiology/Infectious Diseases
 a. Overview
 b. Major Infectious Diseases
 ° AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT,
 Western Blot, HTLV-I/II
 ° Adenovirus
 ° Aeromonas
 ° Anthrax/Bacillus Anthracis
 ° Arboviruses
 ° Babesiosis
 ° Bacillary Epithelioid Angiomatosis (BEA)
 and Other Bartonella (Rochalimaea)
 ° Blastocystis Hominis
 ° Brucella
 ° Campylobacter
 ° Candida
 ° Chagas Disease
 ° Chancroid
 ° Chlamydia
 ° Clostridium Difficile
 ° Coronaviruses
 ° Coxsackieviruses
 ° Creutzfeldt-Jakob’s Disease
 ° Cryptosporidium Parvum
 ° Cyclospora Cayetanensis
 ° Cytomegalovirus
 ° Ebola Virus
 ° E. Coli
 ° EchoVirus
 ° Encephalitis
 ° Enteroviruses
 ° Epstein-Barr Virus
 ° Giardia Lamblia
 ° Gonorrhea
 ° Granuloma Inguinale
 ° Hantavirus
 ° Helicobacter Pylori
 ° Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT,
 Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag,
 HBe Ag, ALT/SGPT
 ° Herpes Simplex Virus
 ° Human Herpes Virus-6 (HHV-6)
 ° Influenza Viruses
 ° Legionella
 ° Lyme Disease
 ° Lymphogranuloma Venereum (LGV)
 ° Malaria
 ° Measles (Rubeola)
 ° Meningitis
 ° Microsporidium
 ° Mononucleosis
 ° Mumps
 ° Mycoplasma
 ° Papillomaviruses
 ° Parvovirus B19
 ° Pneumonia
 ° Polyomaviruses
 ° Pseudomonas Aeruginosa
 ° Rabies
 ° Respiratory Syncytial Virus (RSV)
 ° Rhinoviruses
 ° Rotavirus
 ° Rubella
 ° Salmonellosis
 ° Septicemia
 ° Shigellosis
 ° Staphylococcus Aureus
 ° Streptococci
 ° Syphilis
 ° Toxoplasmosis
 ° Trichomonas Vaginalis
 ° Tuberculosis
 ° Vibrio
 ° West Nile Virus
 ° Yersina
 2. Cancer Testing
 a. Overview
 b. Major Cancer Types
 * Prostate
 * Lung
 * Colon and Rectum
 * Breast
 * Skin
 * Uterine
 * Leukemia
 * Oral
 c. Oncogenes
 The report provides review of both current and emerging oncogenes, including:
 O Abl/abl-bcr
 O AIB1
 O BCL-2
 O BRCA1
 O CD44
 O C-fos
 O C-myb
 O C-myc
 O CYP17
 O Erb-B
 O HPC1
 O N-myc
 O P40
 O P51
 O P53
 O PIK3CA
 O PTI-1
 O Ras
 O Reg
 O Sis
 O Src
 3. Genetic Diseases
 a. Overview
 b. Nucleic Acid Amplification
 c. Chromosome Imaging
 d. Genomics Technologies
 e. Proteomics Technologies
 f. Current Pharmacogenomic Tests
 g. Future Pharmacogenomic Testing
 h. Major Diseases
 * Achondroplasia
 * Autosomal Dominant Polycystic Kidney
 Disease
 * Cancer
 * Cosmetogenomics
 * Cystic Fibrosis
 * Downs Syndrome
 * Duchenne and Becker Muscular Dystrophy
 * Factor V (Leiden)
 * Factor IX Deficiency
 * Fragile X Syndrome
 * Heart Disease
 * Hemochomatosis
 * Hemophilia
 * Huntingtons Disease
 * Maternal-Fetal Incompatibility
 * Multiple Endocrine Neoplasia
 * Phenylketonuria (PKU)
 * Polycystic Kidney Disease (PKD)
 * Prenatal Screening
 * Retinitis Pigmentosa
 * Retinoblastoma
 * Sickle Cell Anemia
 * Spinal Muscular Atrophy
 * Vitamin B12 Metabolism
 i. Social Issues and Concerns
 4. Forensic Testing
 a. Overview
 b. Multilocus and Single Locus Probes
 c. The FBI
 d. DNA Profile Data Banks
 e. Judicial Implementation
 f. Major Crime Categories
 g. Factors Contributing to the DNA Probe
 Market Expansion
 h. Wildlife Forensics
 5. Paternity Testing/HLA Typing
 6. Other Applications
 a. Disease Susceptibility Testing
 b. Cardiovascular Diseases
 c. Diabetes
 d. Alzheimers Disease
 e. Periodontal Disease
 f. Plasma Purification
 g. Organ Transplantation
 h. W ater Contamination
 i. Other
 H. Competing/Complementing Technologies
 1. Monoclonal Antibodies/Immunoassays
 2. RNA Probes
 3. Two-Dimensional Electrophoresis
 4. Flow Cytometry
 VII. Molecular Diagnostics Market
 A. Executive Summary
 B. Business Environment
 C. Market Structure
 D. Market Size, Test Volume and Sales Forecasts,
 Major Supplier Sales and Market Shares
 VIII. Competitive Assessments
 The report provides strategic assessments of over 40 leading molecular diagnostics
 market players and start-up companies with innovative technologies and products,
 including:
 Abbott, Agilent Technologies, Beckman Coulter/Danaher, Becton Dickinson,
 bioMerieux, Bio-Rad, Cepheid, DiaSorin, Eiken Chemical, Enzo, Fujirebio, Grifols,
 Hologic, Illumina, LabCorp/Sequenom, Leica Biosystems, Myriad Genetics, OrthoClinical Diagnostics, Qiagen, Quest Diagnostics, Quidel, Roche, Shimadzu,
 Siemens Healthineers, Sierra Molecular, Takara Bio, Tecan Group, Thermo Fisher,
 Wako and others.
 Major Companies Developing or Marketing AIDS Molecular
 Diagnostic and Other Direct Identification Tests
 Major Companies Developing or Marketing Adenovirus
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Bartonella
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Campylobacter
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Candida
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Chlamydia
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Clostridium
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Coronavirus
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Cryptosporidium
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing CMV Molecular
 Diagnostic and Other Direct Identification Tests
 Major Companies Developing or Marketing Echovirus Molecular
 Diagnostic and Other Direct Identification Tests
 Major Companies Developing or Marketing Enterovirus Molecular
 Diagnostic and Other Direct Identification Tests
 Major Companies Developing or Marketing EBV Molecular
 Diagnostic and Other Direct Identification Tests
 Major Companies Developing or Marketing Giardia
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Gonorrhea
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Hantavirus
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Helicobacter
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Hepatitis
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Herpes
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Influenza
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Legionella
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Lyme
 Disease Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Measles
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Meningitis
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Mononucleosis
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Mumps
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Mycoplasma
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Pneumonia
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing RSV
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Rotavirus
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Rubella
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Salmonella
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Septicemia
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Shigella
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Streptococci
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Syphilis
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Toxoplasmosis
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Trichomonas
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Tuberculosis
 Molecular Diagnostic and Other Direct
 Identification Tests
 Oncogenes Potential Application in Cancer Diagnosis
 Major Companies Developing or Marketing Cancer
 Molecular Diagnostic Tests
 Major Companies Developing or Marketing Molecular
 Diagnostic Tests For Genetic Diseases
 Germany
 Molecular Diagnostics Test Volume And Sales
 By Major Application
 Germany
 Laboratories Performing DNA Sequencing
 By Market Segment
 Germany
 Molecular Diagnostics Market
 Potential Laboratory Universe by Market Segment
 Germany
 Molecular Diagnostics Test Volume
 By Major Application
 Germany
 Major Infectious Disease Test Volume by Assay
 Germany
 Major Infectious Disease Test Volume by Method
 Germany
 Molecular Diagnostics Market
 By Major Application
 Germany
 Molecular Diagnostics Market
 Estimated Sales And Market Shares of Major Suppliers
 Germany
 Major Infectious Disease Diagnostics Market by Assay
 Germany
 AIDS Testing Market
 Estimated Sales by Major Supplier
 Germany
 CMV Testing Market
 Estimated Sales by Major Supplier
 Germany
 EBV Testing Market
 Estimated Sales by Major Supplier
 Germany
 Gonorrhea Testing Market
 Estimated Sales by Major Supplier
 Germany
 Hepatitis Testing Market
 Estimated Sales by Major Supplier
 Germany
 Hepatitis C Testing Market
 Estimated Sales by Major Supplier
 Germany
 HIV/Hepatitis Blood Screening NAT Market
 Reagent Sales by Major Supplier
 Germany
 Herpes Testing Market
 Estimated Sales by Major Supplier
 Germany
 Influenza Testing Market
 Estimated Sales by Major Supplier
 Germany
 Meningitis Testing Market
 Estimated Sales by Major Supplier
 Germany
 Mycoplasma Testing Market
 Estimated Sales by Major Supplier
 Germany
 Pneumonia Testing Market
 Estimated Sales by Major Supplier
 Germany
 RSV Testing Market
 Estimated Sales by Major Supplier
 Germany
 Rotavirus Testing Market
 Estimated Sales by Major Supplier 


List Of Tables

Major Companies Developing or Marketing AIDS Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Bartonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Candida
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Clostridium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Coronavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Cryptosporidium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hantavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Helicobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Influenza
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Measles
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Meningitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mononucleosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mumps
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing RSV
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rotavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rubella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Septicemia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Syphilis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Trichomonas
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic and Other Direct
Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer
Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular
Diagnostic Tests For Genetic Diseases
Germany
Molecular Diagnostics Test Volume And Sales
By Major Application
Germany
Laboratories Performing DNA Sequencing
By Market Segment
Germany
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment
Germany
Molecular Diagnostics Test Volume
By Major Application
Germany
Major Infectious Disease Test Volume by Assay
Germany
Major Infectious Disease Test Volume by Method
Germany
Molecular Diagnostics Market
By Major Application
Germany
Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers
Germany
Major Infectious Disease Diagnostics Market by Assay
Germany
AIDS Testing Market
Estimated Sales by Major Supplier
Germany
CMV Testing Market
Estimated Sales by Major Supplier
Germany
EBV Testing Market
Estimated Sales by Major Supplier
Germany
Gonorrhea Testing Market
Estimated Sales by Major Supplier
Germany
Hepatitis Testing Market
Estimated Sales by Major Supplier
Germany
Hepatitis C Testing Market
Estimated Sales by Major Supplier
Germany
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier
Germany
Herpes Testing Market
Estimated Sales by Major Supplier
Germany
Influenza Testing Market
Estimated Sales by Major Supplier
Germany
Meningitis Testing Market
Estimated Sales by Major Supplier
Germany
Mycoplasma Testing Market
Estimated Sales by Major Supplier
Germany
Pneumonia Testing Market
Estimated Sales by Major Supplier
Germany
RSV Testing Market
Estimated Sales by Major Supplier
Germany
Rotavirus Testing Market
Estimated Sales by Major Supplier


Global Medical Imaging Market (2021 Edition) – Analysis By Product (X-Ray, Ultrasound, MRI, CT Scan, Nuclear Imaging), End-User, Application, By Region, By Country: Market Insights and Forecast with Impact of Covid-19 (2021-2026)

Executive Global Medical Imaging Market was valued at USD 39.94 Billion in the year 2020. Medical Imaging refers to use of different imaging modalities to get visual representations of interior

USD 2400 View Report

Global Psychedelic Drugs Market (2021 Edition) – Analysis By Drug, Route of Administration, Distribution Channel, By Region, By Country: Market Insights, Pipeline Drugs and Forecast with Impact of Covid-19 (2021-2026)

Executive The Covid-19 pandemic has restricted the movement of people, confining them in their homes, caused severe trauma and stress in the form of sadness and loneliness and has affected

USD 2200 View Report

2021 Germany Database of Blood Typing, Grouping and Infectious Disease NAT Screening Market--Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.The report is available by section, and can be customized to specific information needs and

USD 3500 View Report

2021 Germany Transfusion Diagnostics Market Asseessment: Supplier Shares and Sales Segment Forecasts

This report provides an overview of the German blood banking market, including sales and market shares of leading suppliers of blood typing, grouping and infectious disease screening/NAT tests, as well

USD 1450 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available